Systemic Lupus Erythematosus Nursing Care Plans

Lupus is an autoimmune disease that can hit almost any system, so your patient may come in for a rash and a sore wrist or for failing kidneys. The immune system loses the ability to tell self from invader and makes autoantibodies that form immune complexes, which lodge in tissue and drive inflammation, damage, and pain. Mild disease stays in joints and skin. Severe disease reaches the kidneys, heart, lungs, vessels, and CNS. Your daily work is controlling pain and fatigue, protecting skin from sun and breakdown, keeping the patient on their medications, and watching for flares and organ involvement (especially the kidney).

What is Systemic Lupus Erythematosus?

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a systemic inflammatory response. The cause is unknown, but genetic, hormonal, and environmental factors are involved.

There are three types. Discoid lupus is limited to the skin and rarely involves other organs. Systemic lupus is more common and usually more severe, can affect any organ system, and runs in remissions and flares. Drug-induced lupus is the third type. The drugs most often implicated are hydralazine (Apresoline), procainamide (Pronestyl), isoniazid (INH), chlorpromazine (Thorazine), d-penicillamine, and some anti-seizure medications. Symptoms typically appear only after months or years of continued use and usually resolve once the drug is stopped.

Nursing Care Plans and Management

Goals include relief of pain and fatigue, intact skin, medication adherence, better understanding of the disease, and no complications.

Nursing Problem Priorities

• Assess for signs and symptoms of SLE.
• Give prescribed medications (corticosteroids, immunosuppressants) to manage disease activity.
• Monitor and document disease progression, organ involvement, and complications.
• Teach medication adherence and side effects.
• Support symptom management and trigger avoidance.

Nursing Assessment

Assess subjective and objective data (see assessment cues under Nursing Interventions and Actions).

Nursing Diagnosis

Formulate diagnoses from your assessment and clinical judgment, prioritizing the patient's actual problems. Common ones in SLE include fatigue, impaired skin integrity, acute pain, risk for infection, disturbed body image, activity intolerance, imbalanced nutrition, deficient knowledge, risk for impaired renal function (lupus nephritis), and anxiety.

Nursing Goals

Goals and expected outcomes:

• The patient copes with hair loss and identifies ways to cover scalp loss as preferred.
• The patient maintains optimal skin integrity, with no rashes or lesions.
• The patient reports pain or stiffness less than 3 to 4 on a 0 to 10 scale.
• The patient follows a pain management plan using pharmacologic and nonpharmacologic measures.
• The patient participates in self-care.
• The patient verbalizes understanding of the disease and its treatment.

Nursing Interventions and Actions

1. Improving Skin Integrity

SLE causes rashes, photosensitivity, and ulcers that affect quality of life and need close attention.

Assess skin integrity. Small lesions may appear on oral and nasal mucous membranes, and disclike maculopapular lesions may appear on the face or chest. Assess the patient's description of pain, since presentations vary.

Assess for an erythematous rash on the face, neck, or extremities. The classic butterfly rash crosses the bridge of the nose and the cheeks and appears in about 50% of patients.

Assess for photosensitivity. Patients may react sharply to ultraviolet light or sunlight, with flares or severe rash after exposure.

Assess how much symptoms interfere with lifestyle and body image. Responses range from ignoring the change to preoccupation with it.

Encourage adequate nutrition and hydration to promote healthy skin and healing.

Instruct the patient to clean, dry, and moisturize intact skin using warm (not hot) water, especially over bony prominences, with unscented lotion and mild shampoo. Scented lotions may contain alcohol that dries skin.

Tell the patient to avoid harsh chemicals, wear protective gloves as needed, and avoid hair dye, permanent solution, and curl relaxers, which aggravate the condition.

Recommend prophylactic pressure-relieving devices (special mattress, elbow pads) to prevent breakdown.

For skin rash, have the patient wear protective eyewear, a wide-brimmed hat, and carry an umbrella, use maximum-protection sunscreen (SPF 15 or above), and avoid ultraviolet rays. Sunbathing is contraindicated, since sun can worsen the rash or precipitate a flare.

Tell the patient that special makeup (available at large department stores) can cover facial rashes, birthmarks, and pigmented areas, which helps with body image.

Reinforce information about hydroxychloroquine. This slow-acting antimalarial reduces inflammation and rash and may take 8 to 12 weeks to take effect. Retinal toxicity is a potential side effect, so the patient must follow up with an ophthalmologist every 6 months. Topical cortisone may also be used.

For oral ulcers, instruct the patient to avoid spicy or citrusy foods that irritate fissures, rinse the mouth with half-strength hydrogen peroxide three times per day to keep ulcers clean, keep ulcerated skin clean and dry with dressings as needed, and apply topical ointments as prescribed. Vitamins A and E may help maintain skin health.

For hair loss, tell the patient that scalp hair loss occurs during exacerbations and may be the first sign of an impending flare. It is usually not permanent and regrows as disease activity subsides. High-dose corticosteroids (prednisone) and immunosuppressants can also cause it, with regrowth as the dose decreases. Encourage scarves, hats, or wigs to conceal loss.

2. Managing Acute Pain and Providing Comfort

SLE inflames joints and tissues, and flares bring acute pain.

Assess the patient's description of pain. Patients often have arthralgias in many joints with morning stiffness. This stiffness is not from overuse but from immune complexes setting up inflammation, and many patients also have arthritis, so discomfort is multifactorial.

Assess how pain and stiffness affect the patient interpersonally, socially, and professionally. SLE arthritis rarely deforms joints the way rheumatoid arthritis does, but it can severely limit activity at times.

Assess for joint inflammation (warmth, redness, swelling) or decreased motion, though usual inflammatory signs may be absent. Assess prior pain measures, since the patient may not have tried all current options and relief measures shift as different joints are affected.

Encourage ambulation aids (crutches, walkers, canes) when pain is weight-bearing. Encourage anatomically correct positioning of all joints: a small flat pillow under the head, no knee gatch or pillow under the knee, to prevent contractures.

Tell the patient to avoid prolonged inactivity, which lets joints stiffen and muscles atrophy. Encourage ROM exercises after a shower or bath, two repetitions per joint, to reduce stiffness and maintain mobility, and to allow extra time for activities when stiff.

Encourage a 15-minute warm shower or bath on arising. Warmth reduces stiffness and pain, but excessive heat promotes skin breakdown.

Encourage splints as ordered to rest inflamed joints and reduce spasm, and nonpharmacologic measures (relaxation, distraction, guided imagery) to augment medication. Suggest a bed cradle to keep covers off inflamed lower extremities.

Instruct the patient to take anti-inflammatory medications as prescribed, with the first dose as early in the morning as possible and a small snack. Earlier dosing means earlier relief, and these drugs should not be taken on an empty stomach. Suggest nonopioid analgesics as needed; opioids work better on mechanical pain than inflammatory pain and can be habit-forming. Consult occupational therapy for proper splinting.

3. Decreasing Fatigue

Fatigue is multifactorial: disease activity, medications, poor sleep, and psychological factors.

Assess the fatigue pattern (afternoon or all day), its relationship to activity, and aggravating and relieving factors, to plan activity around the patient's peak energy. Determine whether fatigue is psychological (stress, depression). Depression is common in chronic painful disease and is treatable. Assess the nighttime sleep pattern, since SLE discomfort disrupts sleep.

Reinforce energy conservation: adequate rest periods, pacing activity with rest, proper use of assistive devices, and organization of activities and environment.

If fatigue is from interrupted sleep, instruct the patient to avoid stimulants (caffeine) and stimulating activity before bed, take a warm bath before bed to relax muscles (avoiding excessive heat), sleep in an anatomically correct position without propping affected joints, use progressive muscle relaxation, change position frequently at night, and do gentle ROM exercises after a shower or bath. Give a nighttime analgesic or long-acting anti-inflammatory as prescribed, since pain relief supports sleep.

4. Patient Education and Health Teaching

Education lets patients recognize early flare signs, manage medications, keep followup appointments, and apply self-care.

Assess the patient's knowledge of the disease, management, and complications, since gaps compromise self-care and coping.

Teach the disease process: unknown cause, chronicity, inflammation and fibrosis, remissions and exacerbations, and control versus cure. Treatment reduces inflammation, minimizes symptoms, and maintains normal function, and good nutrition and exercise reduce flares.

Discuss common diagnostic tests, including antinuclear antibody (ANA), erythrocyte sedimentation rate (ESR), serum protein electrophoresis, rheumatoid factor, and serum complement, plus tests for kidney and liver involvement.

Reinforce drug therapy and teach the side effects of steroids, immunosuppressants, and other SLE drugs (see Pharmacologic Management).

Stress not altering the steroid dose or stopping it suddenly. Steroids must be tapered after high-dose or long-term use, because exogenous steroids suppress the adrenal cortisol the body needs under stress. Stopping abruptly can throw a steroid-dependent patient into Addisonian crisis. The patient should wear a medical alert tag stating they take steroids and immunosuppressants.

Tell the patient to monitor for fever, a common sign of active disease, and to report chills, shaking, and diaphoresis. Patients taking aspirin as an antipyretic need frequent liver studies, since aspirin can cause transient liver toxicity in SLE.

Teach flare-reducing habits: a balanced diet of fruits, grains, and vegetables, regular exercise, sun avoidance, and adequate rest. Offer information on appropriate clinical trials and on community or reputable online support groups.

5. Pharmacologic Management

Antimalarials (chloroquine, hydroxychloroquine) treat skin and joint symptoms. Side effects are rare, but the patient should see an eye physician several times a year to rule out irreversible retinopathy. Mild GI upset can occur.

Corticosteroids provide anti-inflammatory and immunoregulatory effects. Topical preparations work for skin, and oral prednisone may be used for minor disease. Common side effects include facial puffiness, buffalo hump, diabetes mellitus, osteoporosis, avascular necrosis of the hip, cataracts, and increased infection risk.

NSAIDs and COX-2 inhibitors provide anti-inflammatory action. Never take them on an empty stomach. Side effects include GI distress.

Immunosuppressants (mycophenolate mofetil, cyclophosphamide, azathioprine) suppress immune activity to slow the disease, especially in severe flares and renal or CNS involvement. Side effects include infection from marrow suppression, nausea and vomiting, sterility, hemorrhagic cystitis, and cancer.

6. Monitoring Diagnostic and Laboratory Procedures

Antinuclear antibody (ANA) test detects antibodies targeting the cell nucleus and is the primary SLE screen, positive in most cases.

Anti-double-stranded DNA (anti-dsDNA) antibodies are highly specific to SLE and help confirm the diagnosis and track disease activity.

Anti-Smith (anti-Sm) antibodies are highly specific for SLE and aid diagnosis when combined with other findings, though not present in all patients.

Complement tests (C3, C4, and CH50 total hemolytic complement) assess complement activity and monitor disease activity.

Complete blood count (CBC) measures red cells, white cells, and platelets. SLE often causes anemia, leukopenia, or thrombocytopenia.

ESR and C-reactive protein (CRP) assess inflammation and rise in active SLE.

Kidney function tests, including urinalysis, proteinuria measurement, blood urea nitrogen, and creatinine, monitor for lupus nephritis.

Imaging (x-ray, ultrasound, CT) evaluates organ involvement such as joint damage or pleural effusions.

Biopsy confirms organ involvement and assesses activity. A kidney biopsy can diagnose and stage lupus nephritis.

7. Assessing and Monitoring for Potential Complications

Monitor for signs of disease activity: joint pain, skin rashes, fatigue, organ-specific symptoms (renal, cardiac), and changing lab values. Review history and examine the patient regularly to catch new or worsening symptoms early.

Monitor renal function, since SLE can cause lupus nephritis. Track urine output, check urinalysis for proteinuria, and run renal function tests (BUN, creatinine). Early detection allows timely intervention and nephrology referral.

Assess skin regularly for new rashes, lesions, or ulcerations, and report findings for management and dermatology referral if needed.

Monitor medication adherence and side effects. SLE regimens are complex, so confirm the patient understands their importance, teach the side effects, and report any adverse reactions for adjustment.

Provide psychological and emotional support. Chronic illness affects mental health, so assess the patient's psychological state, encourage them to voice concerns, and facilitate counseling or support group referrals as needed.